Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Buys 701,447 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 701,447 shares of the stock in a transaction on Wednesday, June 10th. The stock was bought at an average price of $0.23 per share, for a total transaction of $161,332.81. Following the completion of the transaction, the chief executive officer directly owned 13,263,361 shares of the company’s stock, valued at approximately $3,050,573.03. This trade represents a 5.58% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Cosmos Health Stock Performance

Shares of NASDAQ:COSM opened at $0.21 on Friday. The business’s fifty day moving average price is $0.31 and its two-hundred day moving average price is $0.40. Cosmos Health Inc. has a fifty-two week low of $0.20 and a fifty-two week high of $1.32. The stock has a market capitalization of $12.79 million, a price-to-earnings ratio of -0.32 and a beta of 4.79. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.08 and a quick ratio of 0.92.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Thursday, May 21st. The company reported ($0.06) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.06). Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%.The firm had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $17.93 million. As a group, analysts predict that Cosmos Health Inc. will post -0.06 EPS for the current fiscal year.

Institutional Trading of Cosmos Health

A number of large investors have recently bought and sold shares of COSM. XTX Topco Ltd grew its position in Cosmos Health by 52.1% in the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after acquiring an additional 34,117 shares during the period. Renaissance Technologies LLC grew its position in Cosmos Health by 16.7% in the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock valued at $124,000 after acquiring an additional 55,925 shares during the period. Finally, Citadel Advisors LLC boosted its stake in Cosmos Health by 133.1% in the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after purchasing an additional 128,776 shares in the last quarter. 12.61% of the stock is currently owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.